S. David Ellenbogen, Hologic’s chair and CEO, died unexpectedly June 21 from heart failure. A pioneer of bone densitometry, Ellenbogen cofounded Hologic and served as CEO and chair since its formation 16 years ago. In addition to corporate duties
S. David Ellenbogen, Hologic’s chair and CEO, died unexpectedly June 21 from heart failure. A pioneer of bone densitometry, Ellenbogen cofounded Hologic and served as CEO and chair since its formation 16 years ago. In addition to corporate duties at Hologic, Ellenbogen lobbied state and federal officials on behalf of small companies throughout the medical device industry. His professional efforts underscored the integrity and good will that friends and associates experienced firsthand. Jay A. Stein, executive vice president and CTO, has been appointed Hologic chair. Stein will serve as interim CEO, until the company’s board of directors fills the position permanently.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.